Latest 8-K filings

Coya Therapeutics announced the full enrollment of 120 patients in its Phase 2/3 ALSTARS trial for ALS treatment, with topline data expected in early Q2 2027.

Leidos Holdings, Inc. has finalized a joint venture with Altaris, combining its Security Enterprise Solutions and Industrial Automation businesses with Analogic Corporation to enhance global security screening capabilities.

TeraWulf Inc. has amended agreements to double contracted power capacity at its Muskie Data Campus to 1 GW, advancing a key phase by one year.

C.H. Robinson Worldwide, Inc. announced its definitive agreement to acquire RXO Inc. for an implied value of $5.8 billion, aiming to create a combined logistics powerhouse with significant synergy potential.

Red Robin Gourmet Burgers, Inc. announced the completion of its credit facility refinancing, a key step in its 'First Choice Plan' aimed at strengthening its balance sheet.

Hudson Pacific Properties' operating partnership is initiating a cash tender offer to repurchase up to $200 million of its outstanding senior notes due 2027 and 2028.

DeFi Development Corp. announced preliminary Q3 2026 estimates showing significant growth in SOL per share and NAV per share, alongside the successful launch of its CHAD preferred stock.

C.H. Robinson Worldwide, Inc. has entered into a definitive agreement to acquire RXO Inc. in a stock-and-cash transaction valued at $5.8 billion, aiming to create a more scaled and resilient North American third-party logistics provider.

Benitec Biopharma announced receipt of formal FDA feedback on BB-301, with pivotal study design confirmation expected in 1Q 2027 and enrollment targeted for mid-2027.

Flex Ltd. announced a $2.0 billion Series A Convertible Preferred Stock investment into its Cloud and Power Infrastructure segment, Axiom, led by General Catalyst and Koch Equity Development, to support its upcoming spin-off.

FTC Solar has amended its credit agreement, deferring a $5 million repayment and adjusting financial covenants to provide greater operational flexibility.

Stablecoin Development Corporation reports a significant increase in its SKY token holdings and staking rewards as of September 30, 2026, with a strategic focus on digital asset exposure.

TELA Bio announced U.S. FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh for soft tissue reinforcement.

Forum Markets, Inc. has established a joint venture with Edge Node Inc. to deploy AI compute infrastructure across the U.S., targeting existing powered data sites and communication towers.

Butterfly Network announced the appointment of Mike Noonen, a seasoned semiconductor executive with extensive experience in scaling chip companies, to its Board of Directors, effective October 9, 2026.

Vaxcyte announces positive topline data from its Phase 3 OPUS-1 trial for VAX-31, a 31-valent pneumococcal conjugate vaccine candidate, meeting all primary endpoints for safety, tolerability, and immunogenicity.

SS Innovations International, Inc. showcased robust growth in surgical robotic system installations, procedures, and revenue in its October 2026 Company Presentation, detailing progress in global market penetration and upcoming regulatory milestones.

Jasper Therapeutics' stockholders approved a reverse stock split and an increase in authorized shares at a special meeting, providing the company with greater financial and strategic flexibility.

Quality Industrial Corp. has filed amended articles of incorporation, increasing authorized common stock and altering corporate governance provisions.

Strategy Inc. reported on its At-the-Market (ATM) offering, Bitcoin (BTC) holdings, and share repurchase programs, highlighting a substantial gain on digital assets for Q3 2026 and a significant release of a deferred tax valuation allowance.

Rezolute, Inc. announced the FDA recommended a pre-Biologics License Application (BLA) meeting for its drug ersodetug to treat congenital hyperinsulinism, despite the drug not meeting primary trial endpoints.

Strive, Inc. announced the purchase of 2,000 bitcoin and provided an update on its cash, bitcoin, and stock holdings as of early October 2026.

Distribution Solutions Group, Inc. (DSG) announced plans for a $700 million Senior Notes offering to fund its previously announced merger, where affiliates of LKCM Headwater Investments will acquire outstanding shares for $35.00 each.

Matador Resources Company announced the successful closing of its acquisition of Paloma Permian LLC for approximately $1.255 billion, significantly expanding its Delaware Basin acreage.

Harrow, Inc. has completed the acquisition of TYRVAYA (varenicline solution) nasal spray, a differentiated treatment for dry eye disease, from Viatris Inc., expanding its ocular surface franchise.

Schneider Electric announced its definitive agreement to acquire PTC Inc. for $205 per share in an all-cash transaction, valuing PTC's equity at approximately $22.6 billion.

Processa Pharmaceuticals, Inc. has amended its Form 8-K to provide updated financial information following its acquisition of Vidya Therapeutics, Inc., including $200 million in gross proceeds from a private placement.

Neighborhood Intelligence and Fathom Holdings have mutually agreed to terminate their previously announced merger agreement, citing current valuations and strategic priorities.

Insmed Incorporated announced that Chief Financial Officer Sara Bonstein will step down on October 30, 2026, while reaffirming its full-year 2026 financial guidance for BRINSUPRI and ARIKAYCE.

Tidewater Inc. has amended its BNDES Construction Loans, replacing legacy parent company guarantees with its own and adjusting interest rates and collateral requirements.